Condition 101 About Distomatosis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Distomatosis

GV
Elite
Govert J. Van Dam
Leiden, ZH, NL
AB
Elite
Amaya L. Bustinduy
Pediatrics
Chicago, IL
LV
Elite
Lisette A. Van Lieshout
Leiden, ZH, NL
DR
Elite
David Rollinson
London, ENG, GB
JW
Elite
Joanne P. Webster
London, ENG, GB
CD
Elite
Claudia J. De Dood
Leiden, ZH, NL
View All Doctors

Latest Advances On Distomatosis

  • Condition: Intestinal Schistosomiasis
  • Journal: PLoS neglected tropical diseases
  • Treatment Used: Praziquantel and Dihydroartemisinin Piperaquine Combination
  • Number of Patients: 639
  • Published —
The study researched the outcomes of praziquantel and dihydroartemisinin piperaquine combination for treating intestinal schistosomiasis.
  • Condition: Human Schistosomiasis
  • Journal: PLoS neglected tropical diseases
  • Treatment Used: CIDD-00149830 and CIDD-0072229
  • Number of Patients: 0
  • Published —
The study researched the outcomes of CIDD-00149830 and CIDD-0072229 in treating human schistosomiasis.
View All Latest Advances

Clinical Trials For Distomatosis

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 300
  • Start Date: October 21, 2021
A Phase IV, Multi-center, Open-label Study to Determine the Safety, Tolerability and Clinical Outcomes Following Oral Administration of EGATEN™ (Triclabendazole) in Patients (6 Years of Age or Older) With Fascioliasis.
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 600
  • Start Date: February 1, 2021
Phase II PK/PD Driven Dose Finding Trial of Praziquantel in Children Under Four
View All Clinical Trials